CAS: 496775-61-2 - Eltrombopag
Formula:C25H22N4O4
InChI:InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,26,30H,1-3H3,(H,32,33)/b27-22-
InChI key:InChIKey=XDXWLKQMMKQXPV-QYQHSDTDSA-N
SMILES:O=C(O)C=1C=CC=C(C1)C=2C=CC=C(NN=C3C(=O)N(N=C3C)C4=CC=C(C(=C4)C)C)C2O
- Synonyms:
- 3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
- 3′-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid
- Sb 497115
- [1,1′-Biphenyl]-3-carboxylic acid, 3′-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy-
- [1,1′-Biphenyl]-3-carboxylic acid, 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-
Ref: IN-DA00DA6A
1g | 124.00 € | ||
5g | 304.00 € | ||
25g | To inquire | ||
25mg | 36.00 € | ||
50mg | 52.00 € | ||
100mg | 62.00 € | ||
250mg | 65.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ref: 4Z-E-482
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-E-481
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 7W-GP0470
Undefined size | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Eltrombopag
CAS:496775-61-2
Eltrombopag (SB-497115-GR), an orally active thrombopoietin receptor agonist with megakaryopoiesis stimulating activity, binds to and …
Formula:
C25H22N4O4
Purity:
99.73%
Color and Shape:
Orange To Red Solid
Molecular weight:
442.47
Ref: TM-T2562
5mg | 52.00 € | ||
10mg | 72.00 € | ||
25mg | 115.00 € | ||
50mg | 149.00 € | ||
100mg | 182.00 € | ||
200mg | 276.00 € | ||
500mg | 458.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Eltrombopag
Controlled ProductCAS:496775-61-2
Formula:
C25H22N4O4
Color and Shape:
Orange
Molecular weight:
442.47
Ref: TR-E508000
5mg | 155.00 € | ||
10mg | 240.00 € | ||
100mg | 511.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Eltrombopag
CAS:496775-61-2
Agonist of thrombopoietin receptor TpoR, which triggers activation of the JAK2/STAT5 signalling pathway. Eltrombopag is …
Formula:
C25H22N4O4
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
442.47 g/mol
Ref: 3D-FE22658
1g | 409.00 € | ||
2g | 580.00 € | ||
100mg | 151.00 € | ||
250mg | 182.00 € | ||
500mg | 272.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Eltrombopag - Bio-X ™
CAS:496775-61-2
Eltrombopag is an agonist of thrombopoietin receptor TpoR, which triggers activation of the JAK2/STAT5 signalling …
Formula:
C25H22N4O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
442.47 g/mol
Ref: 3D-BE164406
10mg | 136.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Eltrombopag-d9
Controlled ProductCAS:496775-61-2
Formula:
C25D9H13N4O4
Color and Shape:
Neat
Molecular weight:
451.522
Ref: TR-E508004
100mg | 9,065.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Eltrombopag-d3
Controlled ProductCAS:496775-61-2
Applications Eltrombopag-d3 is an isotopic analog of Eltrombopag (E508000) which is an agonist of the …
Formula:
C25D3H19N4O4
Color and Shape:
Neat
Molecular weight:
445.485
Ref: TR-E508003
25mg | 2,172.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025